PULMONX
Pulmonx is the global leader in interventional procedures for the treatment of COPD. It develops and markets non-surgical technologies for the assessment and treatment of patients with severe emphysema, a progressive and life-threatening form of COPD. The Pulmonx solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite m... edical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The technology is supported by a compelling body of clinical evidence including over 100 published scientific articles regarding the clinical benefits of Zephyr Valves. FDA granted the Zephyr Valve a ‘breakthrough device’ designation, and in June 2018 Pulmonx received FDA pre-market approval to commercialize our Zephyr Valve. The Zephyr Valve is now commercially available and physicians in more than 25 countries around the world routinely use the Zephyr Valves to improve the lives of patients with severe emphysema, with over 76,000 valves used to treat more than 19,000 patients worldwide to date.
PULMONX
Industry:
Health Care Medical Device
Founded:
1998-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.pulmonx.com
Total Employee:
251+
Status:
Active
Contact:
650-364-0400
Email Addresses:
[email protected]
Total Funding:
276.93 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Wordpress Plugins Global Site Tag
Similar Organizations
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
Channel Medsystems
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-01-08 | Aeris Therapeutics | Aeris Therapeutics acquired by Pulmonx | N/A |
| 2009-05-13 | Emphasys Medical | Emphasys Medical acquired by Pulmonx | N/A |
Investors List
Adage Capital Management
Adage Capital Management investment in Series H - Pulmonx
Ally Bridge Group
Ally Bridge Group investment in Series H - Pulmonx
CIBC Innovation Banking
CIBC Innovation Banking investment in Debt Financing - Pulmonx
Partner Fund Management
Partner Fund Management investment in Series H - Pulmonx
HealthQuest Capital
HealthQuest Capital investment in Series H - Pulmonx
Rock Springs Capital
Rock Springs Capital investment in Series H - Pulmonx
Latterell Venture Partners
Latterell Venture Partners investment in Series G - Pulmonx
RTW Investments LLC
RTW Investments LLC investment in Series G - Pulmonx
Boston Scientific
Boston Scientific investment in Series G - Pulmonx
Driehaus Capital Management
Driehaus Capital Management investment in Series G - Pulmonx
Official Site Inspections
http://www.pulmonx.com Semrush global rank: 415.41 K Semrush visits lastest month: 131.41 K
- Host name: 94.142.73.34.bc.googleusercontent.com
- IP address: 34.73.142.94
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
